Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
Hereditary nonpolyposis colorectal carcinoma (HNPCC), or Lynch syndrome, is an autosomal dominant syndrome accounting for 5 to 10% of the total colorectal cancer population. Patients with this syndrome develop colorectal carcinoma at an early age, but disease onset can happen in all age groups. Usually the carcinomas are synchronous or metachronous, and most of them arise proximal to the splenic flexure. The prognosis is better than for the sporadic form of cancer, and there is increased risk for cancer development in certain extracolonic sites, such as the endometrium, ovary, stomach, small bowel, hepatobiliary tract, ureter, and renal pelvis. Most patients with HNPCC have a mutation in one of two DNA mismatch repair genes, hMSH2 or hMLH 1. More than 90% of colorectal carcinoma patients with hMSH2 or hMLH1 demonstrate high-frequency microsatellite instability (MSI-H). If a patient is suspected to belong to an HNPCC family, the first screening test should be immunohistochemistry for the detection of hMLH1 and hMSH2 proteins, and if it is indicative, it should be followed by genomic sequencing for the identification of mutations in the mismatch repair genes. Genetic counseling and surveillance for high risk HNPCC family members should begin at age 25. Surveillance includes annual colonoscopy of the entire large bowel, with fecal occult blood testing performed twice a year. Systematic surveillance and individually designed treatment of affected patients may help to detect cancers at an earlier stage and subsequently improve the prognosis of the disease further.
Kouraklis
Gregory
G
Second Department of Propedeutic Surgery, Athens University School of Medicine, Laiko Hospital, Athens, Greece. gkouraklis@hotmail.com
Misiakos
Evangelos P
EP
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics; D005817:Genetic Counseling; D018095:Germ-Line Mutation; D006801:Humans; D018895:Microsatellite Repeats; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein; D009363:Neoplasm Proteins / Q000235:genetics; D009687:Nuclear Proteins; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; C501486:MLH1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; C497172:MSH2 protein, human; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein
Anticancer Res. 1994 Jul-Aug;14(4B):1661-4
7979204
Dis Colon Rectum. 1986 Dec;29(12):849-53
3024933
Anticancer Res. 1993 Sep-Oct;13(5C):1793-4
8267384
Cancer. 1990 Nov 15;66(10):2233-8
2224779
Ann Intern Med. 1984 May;100(5):700-1
6712034
Cancer Res. 1998 Nov 15;58(22):5248-57
9823339
Natl Cancer Inst Monogr. 1985 Dec;69:43-6
3834343
Cancer. 2002 Dec 1;95(11):2422-30
12436451
Cancer. 1971 Jun;27(6):1505-11
5088221
Cancer. 1998 Jul 15;83(2):259-66
9669808
Anticancer Res. 1994 Jul-Aug;14(4B):1631-4
7979198
J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
14970275
Mod Pathol. 1990 May;3(3):332-5
2362940
Cell. 1993 Dec 3;75(5):1027-38
8252616
J Clin Oncol. 2003 Mar 15;21(6):1174-9
12637487
Science. 1993 May 7;260(5109):816-9
8484122
Hum Mol Genet. 1996 Sep;5(9):1245-52
8872463
Hum Mutat. 1997;10 (2):89-99
9259192
Nature. 1993 Jun 10;363(6429):558-61
8505985
Gastroenterology. 1997 Oct;113(4):1146-58
9322509
N Engl J Med. 2003 Mar 6;348(10):919-32
12621137
Cancer. 1988 Feb 15;61(4):829-34
3338040
Ann Intern Med. 2003 Apr 1;138(7):560-70
12667026
Gastroenterology. 1986 Feb;90(2):486-9
3940919
Cancer. 1998 Jul 15;83(2):201-3
9669800
Nat Med. 1996 Feb;2(2):169-74
8574961
Dis Colon Rectum. 2003 Mar;46(3):305-12
12626904
Science. 1993 May 7;260(5109):810-2
8484120
Ann Oncol. 2003 Oct;14(10):1530-6
14504054
N Engl J Med. 1998 May 21;338(21):1481-7
9593786
J Med Genet. 1999 Nov;36(11):801-18
10544223
Gastroenterol Clin North Am. 1988 Dec;17(4):679-712
3068137
J Natl Cancer Inst. 1997 Dec 3;89(23):1758-62
9392616
Arch Intern Med. 1966 Feb;117(2):206-12
5901552
Am J Med. 1987 Nov;83(5):981-3
2823605
Nat Genet. 1993 Nov;5(3):279-82
7903889
Gastroenterology. 1986 Feb;90(2):328-33
3940911
Nature. 1994 Mar 17;368(6468):258-61
8145827
Cancer. 2001 Jun 15;91(12):2417-22
11413533
Nature. 2001 May 17;411(6835):366-74
11357144